Scholars Central

Research articlePublished 2015

Duration of Chemotherapies in Phase III Studies on Metastatic Colorectal Cancer Treated With a Continuous Approach: A Seven-Year Survey

Authors: Alessandro Ottaiano, Maurizio Capuozzo, Guglielmo Nasti, Anna Nappi, Chiara De Divitiis, Monica Capozzi, Salvatore Tafuto, Piera Maiolino, Vincenzo Rosario Iaffaioli

Cancer Science & Therapy

Volume 7 · Issue 7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In last years, many phase III studies have addressed the role of chemotherapy or chemo/biotherapy in metastatic colorectal cancer (mCRC); most of these studies planned their treatment to be continued until disease progression or intolerable toxicity with the aim to obtain a long-term control of the cancer. However, the real duration of this approach might be significantly lower than planned. We made a survey to describe the real duration of chemotherapy in published phase III trials from January 2008 to December 2014. Twenty relevant publications were selected for a total of 48 treatment arms and of 24.475 patients. Median duration of chemotherapy in first-line studies ranged from 4,8 to 7,8 months; in second line from 2,4 to 5,2 months. Most common reasons of discontinuation were: progressive disease (PD), adverse events (AE) and patient request (PR). From 11.0% to 45.0% of patients discontinue treatment for toxicity or their request independently from the efficacy. PR was the third cause ranging from 4,6% to 26,0% of patients; in some studies, it overcame the AE-related withdrawals. Causes of PR for therapy discontinuation should be explored and analyzed to reduce the proportion of withdrawals in phase III studies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Alessandro Ottaiano”
  • BylineArticles whose byline prints “Maurizio Capuozzo”
  • BylineArticles whose byline prints “Guglielmo Nasti”
  • BylineArticles whose byline prints “Anna Nappi”
  • BylineArticles whose byline prints “Chiara De Divitiis”
  • BylineArticles whose byline prints “Monica Capozzi”
  • BylineArticles whose byline prints “Salvatore Tafuto”
  • BylineArticles whose byline prints “Piera Maiolino”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels